IL 22-FC
IL 22-FC Uses, Dosage, Side Effects, Food Interaction and all others data.
IL 22-FC is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).
| Trade Name | IL 22-FC |
| Generic | Efmarodocokin alfa |
| Efmarodocokin alfa Other Names | Efmarodocokin alfa, IL 22-FC, IL-22Fc |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
How IL 22-FC works
IL 22-FC is a human IL-22Fc IgG4 fusion protein that activates the IL-22 pathway being investigated for inflammatory diseases. Studies show activation of STAT3 in primary human hepatocytes and human colon cell lines.
Innovators Monograph
You find simplified version here IL 22-FC
